JHS Svendgaard Laboratories Limited

NSE:JHS.NS

29.48 (INR) • At close September 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 707.982962.067854.9141,000.7241,384.9591,232.6651,389.5681,054.7851,000.855553.239352.796595.9061,266.021,276.954684.583279.943363.75318.641
Cost of Revenue 597.127658.675605.332684.176997.522870.553902.742685.301731.922403.993206.513249.975928.031909.84407.625136.381230.021225.599
Gross Profit 110.855303.392249.582316.548387.437362.112486.826369.484268.933149.247146.283345.931337.989367.114276.959143.562133.7393.042
Gross Profit Ratio 0.1570.3150.2920.3160.280.2940.350.350.2690.270.4150.5810.2670.2870.4050.5130.3680.292
Reseach & Development Expenses 00.6530.6540.0140.3720000000000000
General & Administrative Expenses 045.74816.93317.56921.22221.15618.99618.77213.5420.9919.95415.214092.95672.52550.8239.01417.064
Selling & Marketing Expenses 028.2986.9856.5361.42738.08232.6147.3598.266.5613.50913.338000004.803
SG&A 183.68574.04623.91824.09982.64959.23851.6126.13121.80127.551129.357143.196092.95672.52550.8239.01421.866
Other Expenses 43.144143.97735.17115.7822.5056.9493.304302.389278.5743.31933.991124.42760.38595.99685.47149.43726.79111.184
Operating Expenses 183.685469.05299.831279.828415.816375.837401.686328.52300.375303.877331.921364.215243.515188.951157.996100.25765.80633.05
Operating Income -72.83-69.817-41.8693.554-29.155-31.83185.1440.964-31.442-154.63-185.638-18.28494.474178.163118.96243.30567.92459.991
Operating Income Ratio -0.103-0.073-0.0490.004-0.021-0.0260.0610.039-0.031-0.279-0.526-0.0310.0750.140.1740.1550.1870.188
Total Other Income Expenses Net 38.544-148.58542.8996.124-29.27511.382299.09610.762-184.953-66.696-167.33721.38-61.906-37.139-29.964-29.519-27.465-11.752
Income Before Tax -34.286-218.4021.039.678-58.43-20.45384.23651.726-216.395-221.326-352.9743.09632.568141.02488.99813.78640.45848.239
Income Before Tax Ratio -0.048-0.2270.0010.01-0.042-0.0170.2770.049-0.216-0.4-1.0010.0050.0260.110.130.0490.1110.151
Income Tax Expense 6.291-50.64943.924-3.746-9.88-3.777123.691-167.9590.0160.442-64.87740.70921.48518.9268.752-0.0484.944.501
Net Income -40.577-154.638-40.5211.982-19.791-6.806261.492219.686-216.411-221.768-288.097-37.61311.084122.09980.24613.83435.51843.738
Net Income Ratio -0.057-0.161-0.0470.012-0.014-0.0060.1880.208-0.216-0.401-0.817-0.0630.0090.0960.1170.0490.0980.137
EPS -0.52-2.38-0.630.2-0.32-0.114.295.45-8.42-9.2-11.96-1.560.668.415.861.072.844.93
EPS Diluted -0.52-2.38-0.630.19-0.32-0.114.293.69-8.42-9.2-11.96-1.560.658.415.551.062.844.93
EBITDA -9.37252.96882.723133.346153.70380.153180.735105.30174.142-30.16526.137117.97167.459247.702160.4273.75487.29866.047
EBITDA Ratio -0.0130.0550.0970.1330.1110.0650.130.10.074-0.0550.0740.1980.1320.1940.2340.2630.240.207